{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-07-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Completed",
      "city": "Houston",
      "state": "TX",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "93496",
      "recalling_firm": "Wells Pharma of Houston LLC",
      "address_1": "9265 Kirby Dr",
      "address_2": "",
      "postal_code": "77054-2520",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Telephone",
      "distribution_pattern": "Philadelphia, Pennsylvania.",
      "recall_number": "D-0141-2024",
      "product_description": "ceFAZolin sodium in Sterile Water for injection, Injectable Solution, 1g/10mL (0.1 g per mL), Syringe, Rx only, Wells Pharma, NDC 73702-131-10",
      "product_quantity": "825 syringes",
      "reason_for_recall": "Lack of assurance of sterility.",
      "recall_initiation_date": "20231122",
      "center_classification_date": "20231206",
      "report_date": "20231213",
      "code_info": "Lot # 11092313110#01, Exp 01/12/24",
      "more_code_info": ""
    }
  ]
}